TNF and uveitis: Although the systemic use of TNF-α inhibitors is an appropriate off-label alternative to “traditional” immunosuppressive and immune-modulatory treatments in noninfectious uveitis, its use in vascular and neovascular retinal diseases has not yet been thoroughly examined.